Malignant Hepatobiliary Neoplasm — Trials

Malignant Hepatobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,025 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,159
Recruiting: 665
Ph III recruiting: 61
Growth YoY: +9%
Industry share: 22%
Top sponsor: Sun Yat-sen University
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (560)

clinicaltrialsPublishedShowing 51–61 of 61 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06041477	Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC(HAIC)	recruiting	Phase 3	540	Sun Yat-sen UniversityOTHER	1	Aug 27, 2024	clinicaltrials
NCT06478108	Interventional Software for Multi-immunotherapy of Solid Tumors	recruiting	Phase 2 / Phase 3	60	Second Affiliated Hospital of Guangzhou Medical UniversityOTHER	1	Jun 27, 2024